News
INGELHEIM, Germany and RIDGEFIELD, Conn., April 28, 2025 /PRNewswire/ -- Boehringer Ingelheim reported new and updated data from the Beamion LUNG-1 trial evaluating zongertinib in previously treated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback